1. Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity
2. Placebo-Controls in Short-Term Clinical Trials of Hypertension
3. Association of American Universities. (2000)Task Force on Research Accountability: Report on University Protection of Human Beings Who Are the Subjects of Research. Washington DC June 28 2000. Available at:http://www.aau.edu/HumSUbRpt06.28.00pdf(accessed April 7 2016).
4. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
5. BohazchukW. (1998)Ethics committee and IRB audit results.Good Clinical Practice pp.46–55.